Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Daniel F. Boyer"'
Autor:
Naomi F. Briones, Trilokraj Tejasvi, Lori Lowe, Alexandra C. Hristov, John S. Runge, Ryan A. Wilcox, Daniel F. Boyer, Madison L. Novice, Kiyanna Williams
Publikováno v:
Journal of Cutaneous Pathology. 49:299-305
The DUSP22-IRF4 gene rearrangement results in downregulation of DUSP22, a presumed tumor suppressor in T-cell lymphomagenesis. It has been described in some cases of primary cutaneous and systemic anaplastic large-cell lymphoma, lymphomatoid papulosi
Autor:
Stephanie L. Skala, Alexandra C. Hristov, Paul W. Harms, Ryan A. Wilcox, Douglas R. Fullen, Trilokraj Tejasvi, Daniel F. Boyer, Noah A. Brown
Publikováno v:
Journal of Cutaneous Pathology. 48:632-636
Follicle center lymphomas, including primary cutaneous follicle center lymphoma, may rarely show plasmacytic differentiation. Such cases can pose a diagnostic challenge and can be mistaken for other lymphomas that more commonly include plasma cells.
Autor:
Winston Y Lee, Noah A. Brown, Sarah Choi, Madelyn Lew, Daniel F. Boyer, Bryan L. Betz, Shannon A. Carty
Publikováno v:
Acta Cytologica. 65:105-110
Fine needle aspiration (FNA) has become increasingly popular in the evaluation of lymph nodes for lymphoproliferative disorders, but there are limitations to accurate subclassification of lymphoma using morphology alone. This case aims to expand diag
Autor:
Patrick W. Burke, Lydia L. Benitez, Anthony J. Perissinotti, Justin H Reid, Bernard L. Marini, Winston Y Lee, Kristen Pettit, Daniel F. Boyer, Dale L. Bixby
Publikováno v:
Leukemia research. 103
Background Acute leukemia with mixed-phenotype blasts is associated with poor outcomes. There are no standard treatment regimens. Due to disease heterogeneity, controversy exists over whether an AML-based, ALL-based, or a combined (hybrid) AML/ALL-ba
Autor:
Daniel F. Boyer
Publikováno v:
Archives of Pathology & Laboratory Medicine. 140:1060-1067
Evaluation of peripheral blood and bone marrow for an indication of persistent eosinophilia can be a challenging task because there are many causes of eosinophilia and the morphologic differences between reactive and neoplastic causes are often subtl
Autor:
Robert A. Redd, Nancy L. Harris, Jeremy S. Abramson, Daniel F. Boyer, Jacob R. Bledsoe, Ha T. Nishino, Aliyah R. Sohani, Judith A. Ferry, Robert P. Hasserjian, Lawrence R. Zukerberg, Jacob D. Soumerai
Publikováno v:
American Journal of Hematology. 91:E436-E441
Primary mediastinal large B-cell lymphoma (PMBL) is a distinct subtype of diffuse large B-cell lymphoma (DLBCL) that shows overlap with classical Hodgkin lymphoma (CHL) and a favorable prognosis compared to mediastinal gray-zone lymphoma (MGZL). We p
Publikováno v:
Archives of pathologylaboratory medicine. 142(11)
Composite lymphomas have been defined as 2 distinct subtypes of lymphoma occurring at a single anatomic site. Composite lymphomas limited to the skin are a rare occurrence and pose a unique challenge. Many reported cases within the skin are combined
Autor:
Daniel F. Boyer, Nathan J. Charles
Publikováno v:
Archives of pathologylaboratory medicine. 141(11)
Mixed-phenotype acute leukemia (MPAL) is a heterogeneous category in the World Health Organization classification that comprises acute leukemias with discrete admixed populations of myeloid and lymphoid blasts (“bilineal”) or with extensive coexp
Autor:
Aliyah R. Sohani, Ha T. Nishino, Alan K. Meeker, Penelope A. McKelvie, Laurence de Leval, Lawrence M. Weiss, Judith A. Ferry, Stefania Pittaluga, Aneal Masih, Young Hyeh Ko, Alexandra E. Kovach, Valentina Nardi, Kerstin L. Edlefsen, Zachary A. Aberman, Lina Shao, Maryknoll Palisoc, Nancy L. Harris, Daniel F. Boyer
Publikováno v:
The American journal of surgical pathology. 41(3)
Incidental cases of localized fibrin-associated Epstein-Barr virus (EBV)+ large B-cell proliferations have been described at unusual anatomic sites and have been included in the category of diffuse large B-cell lymphoma associated with chronic inflam
Publikováno v:
American Journal of Surgical Pathology. 38:279-288
Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is relatively common, and patients occasionally develop other neoplasms; however, patients who develop other types of lymphomas are rare. We encountered 3 patients with CLL/SLL (one 59